Phosphorylated S6 kinase and S6 ribosomal protein are diagnostic markers of antibody-mediated rejection in heart allografts.
暂无分享,去创建一个
M. Fishbein | D. Gjertson | E. Reed | J. Kobashigawa | M. Deng | Chi K. Lai | Fang Li | N. Valenzuela | Qiuheng Zhang | Jennifer Wei
[1] Mary E. Ziegler,et al. Everolimus Inhibits Anti‐HLA I Antibody‐Mediated Endothelial Cell Signaling, Migration and Proliferation More Potently Than Sirolimus , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[2] A. Angelini,et al. The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[3] X. Jouven,et al. Pathologic classification of antibody-mediated rejection correlates with donor-specific antibodies and endothelial cell activation. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[4] E. Reed,et al. HLA Class I Antibodies Trigger Increased Adherence of Monocytes to Endothelial Cells by Eliciting an Increase in Endothelial P-Selectin and, Depending on Subclass, by Engaging FcγRs , 2013, The Journal of Immunology.
[5] E. Reed,et al. HLA class I: an unexpected role in integrin β4 signaling in endothelial cells. , 2012, Human immunology.
[6] M. Fishbein,et al. Morphologic and immunohistochemical findings in antibody-mediated rejection of the cardiac allograft. , 2012, Human immunology.
[7] Mary E. Ziegler,et al. HLA class I-mediated stress fiber formation requires ERK1/2 activation in the absence of an increase in intracellular Ca2+ in human aortic endothelial cells. , 2012, American journal of physiology. Cell physiology.
[8] E. Reed,et al. HLA class I antibody-mediated endothelial and smooth muscle cell activation , 2012, Current opinion in organ transplantation.
[9] M. Haas. Pathologic features of antibody-mediated rejection in renal allografts: an expanding spectrum , 2012, Current opinion in nephrology and hypertension.
[10] Mary E. Ziegler,et al. Characterization of the Endothelial Cell Cytoskeleton following HLA Class I Ligation , 2012, PloS one.
[11] E. Reed,et al. Antibody ligation of human leukocyte antigen class I molecules stimulates migration and proliferation of smooth muscle cells in a focal adhesion kinase-dependent manner. , 2011, Human immunology.
[12] J. Kobashigawa,et al. Cardiac allograft rejection. , 2011, The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland.
[13] A. Angelini,et al. The ISHLT working formulation for pathologic diagnosis of antibody-mediated rejection in heart transplantation: evolution and current status (2005-2011). , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[14] M. Haas,et al. C4d-negative antibody-mediated rejection in renal allografts: evidence for its existence and effect on graft survival. , 2011, Clinical nephrology.
[15] A. Angelini,et al. Report from a consensus conference on antibody-mediated rejection in heart transplantation. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[16] J. Empana,et al. Significance of C4d Banff Scores in Early Protocol Biopsies of Kidney Transplant Recipients with Preformed Donor‐Specific Antibodies (DSA) , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[17] E. Reed,et al. HLA Class I Molecules Partner with Integrin β4 to Stimulate Endothelial Cell Proliferation and Migration , 2010, Science Signaling.
[18] R. Starling,et al. International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[19] E. Reed,et al. Effect of Antibodies on Endothelium , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[20] Paul Aurora,et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Heart Transplant Report-2009. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[21] E. Reed,et al. Human leukocyte antigen antibodies in chronic transplant vasculopathy-mechanisms and pathways. , 2009, Current opinion in immunology.
[22] R. Sodian,et al. Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant. , 2008, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation.
[23] E. Reed,et al. MHC class I and integrin ligation induce ERK activation via an mTORC2-dependent pathway. , 2008, Biochemical and biophysical research communications.
[24] W. Baldwin,et al. In Vivo Platelet–Endothelial Cell Interactions in Response to Major Histocompatibility Complex Alloantibody , 2008, Circulation research.
[25] E. Reed,et al. HLA Class I Antibody-Mediated Endothelial Cell Proliferation via the mTOR Pathway1 , 2008, The Journal of Immunology.
[26] F. Gao,et al. Anti-MHC Class I Antibody Activation of Proliferation and Survival Signaling in Murine Cardiac Allografts1 , 2008, The Journal of Immunology.
[27] Y. Korin,et al. RNA Interference Elucidates the Role of Focal Adhesion Kinase in HLA Class I-Mediated Focal Adhesion Complex Formation and Proliferation in Human Endothelial Cells1 , 2007, The Journal of Immunology.
[28] E. Trulock,et al. Registry of the International Society for Heart and Lung Transplantation: tenth official pediatric lung and heart/lung transplantation report--2007. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[29] M. Fishbein,et al. Phosphorylated S6 Ribosomal Protein: A Novel Biomarker of Antibody‐Mediated Rejection in Heart Allografts , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[30] O. Meyuhas,et al. Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. , 2006, Trends in biochemical sciences.
[31] H. Valantine,et al. Everolimus (certican) in heart transplantation: optimizing renal function through minimizing cyclosporine exposure. , 2005, Transplantation proceedings.
[32] S. Dunlap,et al. The Presence of HLA-Directed Antibodies after Heart Transplantation Is Associated with Poor Allograft Outcome , 2005, Transplantation.
[33] R. Starling,et al. Analysis of immune markers in human cardiac allograft recipients and association with coronary artery vasculopathy. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[34] S. Saidman,et al. C4d deposition in cardiac allografts correlates with alloantibody. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[35] D. Mancini,et al. Anti-Human Leukocyte Antigen Antibodies are Associated with Restenosis after Percutaneous Coronary Intervention for Cardiac Allograft Vasculopathy , 2005, Transplantation.
[36] P. Nickerson,et al. National Conference to Assess Antibody‐Mediated Rejection in Solid Organ Transplantation , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[37] M. Fishbein,et al. Anti-HLA class I antibody-mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cells. , 2004, Human immunology.
[38] W. Baldwin,et al. Beyond C4d: Other Complement‐Related Diagnostic Approaches to Antibody‐Mediated Rejection , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[39] M. Mihatsch,et al. Kidney transplants, antibodies and rejection: is C4d a magic marker? , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[40] E. Tuzcu,et al. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. , 2003, The New England journal of medicine.
[41] M. Mehra,et al. C-Reactive protein and cardiac allograft vasculopathy. is inflammation the critical link? , 2003, Journal of the American College of Cardiology.
[42] Paul S Mischel,et al. Analysis of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma patients in vivo. , 2003, Cancer research.
[43] L. Aicher,et al. Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors. , 2002, Cancer research.
[44] E. Reed,et al. Ligation of HLA Class I Molecules on Endothelial Cells Induces Phosphorylation of Src, Paxillin, and Focal Adhesion Kinase in an Actin-Dependent Manner1 , 2002, The Journal of Immunology.
[45] R. Colvin,et al. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. , 2002, Journal of the American Society of Nephrology : JASN.
[46] M. Yacoub,et al. ANTIVIMENTIN ANTIBODIES ARE AN INDEPENDENT PREDICTOR OF TRANSPLANT-ASSOCIATED CORONARY ARTERY DISEASE AFTER CARDIAC TRANSPLANTATION1 , 2001, Transplantation.
[47] D. Renlund,et al. Allograft coronary artery disease: clinical correlations with circulating anti-HLA antibodies and the immunohistopathologic pattern of vascular rejection. , 2000, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[48] G. Couper,et al. Role of panel-reactive antibody cross-reactivity in predicting survival after orthotopic heart transplantation. , 1994, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[49] D. Renlund,et al. Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications. , 1989, The Journal of heart transplantation.
[50] T. Fenton,et al. Functions and regulation of the 70kDa ribosomal S6 kinases. , 2011, The international journal of biochemistry & cell biology.
[51] D. Mancini,et al. Pre- and posttransplantation allosensitization in heart allograft recipients: major impact of de novo alloantibody production on allograft survival. , 2011, Human immunology.
[52] A. Rahmel,et al. Registry of the International Society for Heart and Lung Transplantation: Twelfth Official Pediatric Heart Transplantation Report-2009. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[53] Silviu Itescu,et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[54] M. Fishbein,et al. Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. , 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[55] M. Rose. Role of antibodies in transplant-associated cardiac allograft vasculopathy , 2000, Zeitschrift für Kardiologie.
[56] M. Fishbein,et al. Clinical-pathologic features of humoral rejection in cardiac allografts: a study in 81 consecutive patients. , 1995, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.